Market Research Logo

Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review

Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts for skin replacement. The company is also developing ixmyelocel-T technology, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). It has manufacturing facilities in Cambridge, Massachusetts; Ann Harbour, Michigan and Kastrup, Denmark. The company sells its products through cell therapy specialists. Vericel is headquartered in Cambridge, the US.

Vericel Corp Key Recent Developments

Aug 20,2018: Vericel names Jonathan Hopper as chief medical officer
Aug 06,2018: Vericel Reports Record Second Quarter Revenues of $19.0 Million and Raises Full Year 2018 Revenue Guidance
May 08,2018: Vericel Reports First Quarter 2018 Financial Results
Mar 05,2018: Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance
Feb 14,2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Vericel Corp - Key Facts
Vericel Corp - Key Employees
Vericel Corp - Key Employee Biographies
Vericel Corp - Major Products and Services
Vericel Corp - History
Vericel Corp - Company Statement
Vericel Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vericel Corp - Business Description
Product Category: License Revenue
Overview
Performance
Product Category: MACI
Overview
Product Category: Carticel and MACI
Performance
Product Category: Epicel
Overview
Performance
R&D Overview
Vericel Corp - Corporate Strategy
Vericel Corp - SWOT Analysis
SWOT Analysis - Overview
Vericel Corp - Strengths
Vericel Corp - Weaknesses
Vericel Corp - Opportunities
Vericel Corp - Threats
Vericel Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
Vericel Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
Vericel Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 20, 2018: Vericel names Jonathan Hopper as chief medical officer
Aug 06, 2018: Vericel Reports Record Second Quarter Revenues of $19.0 Million and Raises Full Year 2018 Revenue Guidance
May 08, 2018: Vericel Reports First Quarter 2018 Financial Results
Mar 05, 2018: Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance
Nov 07, 2017: Vericel Reports Third-Quarter 2017 Financial Results
Aug 09, 2017: Vericel Reports Second-Quarter 2017 Financial Results
May 10, 2017: Vericel Reports First-Quarter 2017 Financial Results
Apr 10, 2017: Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Mar 10, 2017: Vericel Reports Fourth-Quarter and Year-End 2016 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tabless
Vericel Corp, Key Facts
Vericel Corp, Key Employees
Vericel Corp, Key Employee Biographies
Vericel Corp, Major Products and Services
Vericel Corp, History
Vericel Corp, Other Locations
Vericel Corp, Subsidiaries
Vericel Corp, Key Competitors
Vericel Corp, Ratios based on current share price
Vericel Corp, Annual Ratios
Vericel Corp, Annual Ratios (Cont...1)
Vericel Corp, Interim Ratios
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
Vericel Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
Vericel Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Vericel Corp, Performance Chart (2013 - 2017)
Vericel Corp, Ratio Charts
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
Vericel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report